Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EBIT Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) 35.11103.8952.92-30.54-9.62

What is the latest EBIT Growth ratio of VAISHALI PHARMA ?

The latest EBIT Growth ratio of VAISHALI PHARMA is 35.11 based on Mar2023 Standalone results.
Year EBIT Growth
Mar202335.11
Mar2022103.89
Mar202152.92
Mar2020-30.54
Mar2019-9.62

How is EBIT Growth of VAISHALI PHARMA Trending?

Years EBIT Growth % Change
Mar2023 35.11
-66.20
Mar2022 103.89
96.32
Mar2021 52.92
Positive
Mar2020 -30.54
Negative
Mar2019 -9.62 -

Other Financial Ratios of VAISHALI PHARMA


Compare EBIT Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹178.3 Cr -5.2% -3.6% 16% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹369,570.0 Cr 0.9% 1.2% 63.5% Stock Analytics
CIPLA ₹119,627.0 Cr 2.7% 7.3% 52% Stock Analytics
ZYDUS LIFESCIENCES ₹108,316.0 Cr 9.1% 18% 112.8% Stock Analytics
DIVIS LABORATORIES ₹107,804.0 Cr 3.2% 9.5% 20.2% Stock Analytics
DR REDDYS LABORATORIES ₹97,966.5 Cr -1.6% -2.7% 29.9% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-5.2%

-3.6%

16%

SENSEX

1.7%

1.6%

20.6%


You may also like the below Video Courses